Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Plasma (single spun) (3)
• Saliva (1)
• Serum (2)
• Swab medium (1)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (3)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (2)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (2)
• Freezer temperature logs (2)
• Imaging data (1)
• Microbiological results (1)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (1)
• Pre-analytical data (3)
• Primary care records (1)
• Quality indicators (2)
• Treatment records (2)

Timeframe

• Immediate (2)
• 0 - 3 months (1)
• 3 - 6 months (1)
• > 6 months (3)

Participant Count

• 11 - 100 (1)
• 101 - 500 (1)
• 501 - 1000 (1)
• 1001 - 3000 (1)
• 10001 - 50000 (1)

Sex

• Both sexes (3)

Age Range

• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (1)

Biobank Services

• Ability to recontact (1)
• Data analytics (1)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (1)

Collection Type

• Disease specific (3)
• Population-based (1)

Consent Restriction

• No Commercial restriction (1)
• No Disease area restriction (3)
• No Genetic analysis restriction (2)
• No Human genetic analysis restriction (2)
• No restrictions (0)
• No Project specific restriction (3)
• No Scope of use restriction (3)

Collection Status

• Completed (1)
• In progress (2)

Access Condition

• Open to applicants (1)
• Open only through collaboration (1)
• Access restricted at present (1)

Country

• Brazil (1)
• France (1)
• Uganda (1)

County